“Matthew is an experienced drug hunter who brings energy and enthusiasm to any programs that he is involved in. Matthew made a big impact on the portfolio at Sitryx and was instrumental in establishing projects and driving them through key inflection points, all whilst finding opportunities to develop the team around him. I will follow Matthew's continuing career with great interest and look forward to seeing further novel drug candidates enter the clinic under his guidance.”
About
Experienced, networked, drug discovery and development executive with a history of…
Activity
-
NGM Biopharmaceuticals announce their $122M Series A funding round. Three months after The Column Group acquired NGM Bio to take the biotech…
NGM Biopharmaceuticals announce their $122M Series A funding round. Three months after The Column Group acquired NGM Bio to take the biotech…
Liked by Matthew Fyfe
-
#Asceneuron_sa announces $100 million oversubscribed Series C financing! Today we announce that we have successfully secured a Series C financing…
#Asceneuron_sa announces $100 million oversubscribed Series C financing! Today we announce that we have successfully secured a Series C financing…
Liked by Matthew Fyfe
-
We had a vibrant AIM Squad conversation on the formation of boards for seed stage companies and the associated challenges ;) To see the session…
We had a vibrant AIM Squad conversation on the formation of boards for seed stage companies and the associated challenges ;) To see the session…
Liked by Matthew Fyfe
Experience & Education
-
STORM Therapeutics Limited
View Matthew’s full experience
See their title, tenure and more.
or
Licenses & Certifications
Languages
-
English
Native or bilingual proficiency
-
Spanish
Professional working proficiency
-
French
Elementary proficiency
-
German
Elementary proficiency
Recommendations received
25 people have recommended Matthew
Join now to viewMore activity by Matthew
-
Ian Knowles, Head of Respiratory at Pharmidex, is enjoying the fantastic line up of speakers and poster presentations at the 13th London…
Ian Knowles, Head of Respiratory at Pharmidex, is enjoying the fantastic line up of speakers and poster presentations at the 13th London…
Liked by Matthew Fyfe
-
Great to celebrate Curve Therapeutics' 5 year anniversary last week! Founded back in 2019 and originating from the world-leading Microcycle research…
Great to celebrate Curve Therapeutics' 5 year anniversary last week! Founded back in 2019 and originating from the world-leading Microcycle research…
Liked by Matthew Fyfe
-
𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Stevenage, UK based Autifony Therapeutics has been building a CNS pipeline from its expertise in ion channel drug discovery.…
𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Stevenage, UK based Autifony Therapeutics has been building a CNS pipeline from its expertise in ion channel drug discovery.…
Liked by Matthew Fyfe
-
Another key moment in Brainomix's story, representing a significant advancement in our mission to improve healthcare and create value for our Life…
Another key moment in Brainomix's story, representing a significant advancement in our mission to improve healthcare and create value for our Life…
Liked by Matthew Fyfe
-
🚀🚀🚀 Congratulations to Brandon Capital Portfolio Company CatalYm GmbH on your $150 million Series D announcement. As an early investor, it's been…
🚀🚀🚀 Congratulations to Brandon Capital Portfolio Company CatalYm GmbH on your $150 million Series D announcement. As an early investor, it's been…
Liked by Matthew Fyfe
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Matthew Fyfe in United Kingdom
-
Matthew Fyfe
Relationship Director
-
Matthew Fyfe
-
Matthew Fyfe
Data Scientist at MiTek Industries
-
Matthew Fyfe
11 others named Matthew Fyfe in United Kingdom are on LinkedIn
See others named Matthew Fyfe